Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01118585 · ClinicalTrials.gov registry record · NA
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
A NA study, sponsored by EndoGastric Solutions.
- Completed
- Registry status
- NA
- Development phase
- 278
- Enrollment target
NCT01118585: Completed NA study, sponsored by EndoGastric Solutions.
NCT01118585 is a NA study that has completed, run by EndoGastric Solutions. The registered enrollment target is 278 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01118585, a NA study, has completed, sponsored by EndoGastric Solutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 278 participants
- Enrollment target
Study Summary
The study objective is to evaluate the safety and efficacy of TIF among a broad range of GERD patients treated in routine clinical practice at multiple centers across the United States.
Primary Outcome
GERD symptoms (typical and atypical) will be evaluated using three disease-specific standardized questionnaires: GERD-HRQL (Health-related Quality of Life), GSRS (GERD Symptom Rating Score), and RSI (Reflux Symptom Index).
Interventions
- PROCEDURE TIF Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2010-05 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT01118585 record still lists
NCT01118585 is an interventional study that assigns participants to a tested intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 1 intervention - of which TIF Procedure is the first listed.
NCT01118585 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01118585 about?
NCT01118585 is a clinical study titled "Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)". The study objective is to evaluate the safety and efficacy of TIF among a broad range of GERD patients treated in routine clinical practice at multiple centers across the United States.
What is the current status of trial NCT01118585?
This trial is currently completed. It is a NA study. The enrollment target is 278 participants. The study started on 2010-05. Estimated completion is 2018-12.
What interventions are being tested in trial NCT01118585?
The interventions under investigation include: TIF Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT01118585?
This trial is sponsored by EndoGastric Solutions, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01118585's enrollment target sits among peer trials
278 382nd of 2000 higher than 1,618 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
- NCT05489237 · 278 participants · Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
- NCT05965245 · 278 participants · NA
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia